Related Experiment Video
Updated: Jul 4, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
Atypical protein kinase C phosphorylates IKKalphabeta in transformed non-malignant and malignant prostate cell
Hla Y Win1, Mildred Acevedo-Duncan
1Department of Chemistry, University of South Florida, James A. Haley Veteran Hospital, 13000 Bruce B. Downs Blvd. VAR 151, Tampa, FL 33612, USA.
Abstract:
Mechanistic pathways involving atypical protein kinase C-iota (aPKC-iota) have been targeted in various cancer cells such as lung cancer, brain and prostate due to PKCiota's antiapoptotic function, and role in cell proliferation and cell survival. In the current study, we examined the involvement of PKC-iota in the NF-kappaB pathway following treatment of prostate cells with the pro-inflammatory cytokine tumor necrosis factor alpha (TNFalpha). Results demonstrated that androgen-independent DU-145 prostate carcinoma is insensitive to TNFalpha while transformed non-tumorigenic prostate RWPE-1 cells showed a slight sensitivity to TNFalpha. However, androgen-dependent LNCaP prostate cells are more sensitive to TNFalpha treatment and undergo apoptosis. Results demonstrated that in DU-145 cells, TNFalpha-induced PKC-iota in phosphorylation of IKKalphabeta. In RWPE-1 cells, PKC-zeta phosphorylates IKKalphabeta. Degradation of IkappaBalpha was observed in all three cell lines, allowing NF-kappaB/p65 translocation to the nucleus. Although, IKKalpha is weakly activated in LNCaP cells, the upstream kinase phosphorylation of IKKalphabeta via aPKCs was not observed. Hence, aPKCs may play a role in activation of NFkappaB pathway in prostate cancer cells.
Insights
Atypical protein kinase C-iota (aPKC-iota) activation by tumor necrosis factor alpha (TNFalpha) influences the NF-kappaB pathway in prostate cells. This suggests aPKCs may regulate NF-kappaB signaling in prostate cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Atypical protein kinase C-iota (aPKC-iota) plays a role in cell survival and proliferation, making it a target in various cancers.
- The NF-kappaB pathway is crucial in inflammation and cancer, and its regulation is of significant interest.
Purpose of the Study:
- To investigate the role of aPKC-iota in the NF-kappaB pathway activation in prostate cancer cells treated with tumor necrosis factor alpha (TNFalpha).
Main Methods:
- Prostate cancer cell lines (DU-145, RWPE-1, LNCaP) were treated with TNFalpha.
- Western blotting and immunofluorescence were used to analyze protein phosphorylation, degradation, and nuclear translocation.
Main Results:
- DU-145 cells showed TNFalpha-induced PKC-iota phosphorylation of IKKalphabeta, while RWPE-1 cells showed PKC-zeta involvement.
- IkappaBalpha degradation and NF-kappaB/p65 nuclear translocation occurred in all cell lines.
- LNCaP cells exhibited weak IKKalpha activation, with no observed upstream aPKC phosphorylation of IKKalphabeta.
Conclusions:
- aPKCs may be involved in the activation of the NF-kappaB pathway in prostate cancer cells.
- Differential roles of aPKC-iota and aPKC-zeta in TNFalpha-induced NF-kappaB signaling were observed across different prostate cell lines.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade
Anaphase Promoting Complex

